These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3701538)

  • 1. An approach to setting particulate matter standards for small volume parenterals.
    DeLuca PP; Boddapati S; Haack D; Schroeder H
    J Parenter Sci Technol; 1986; 40(1):2-13. PubMed ID: 3701538
    [No Abstract]   [Full Text] [Related]  

  • 2. Particulate matter in small volume parenterals: evaluation of some technological and analytical aspects.
    Cirannni Signoretti E; Montanari I; Neri G; De Sena C; Alimonti S
    Boll Chim Farm; 1989 Feb; 128(2):65-70. PubMed ID: 2775519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visible particle limits in small volume parenterals.
    Leelarasamee N; Howard SA; Baldwin HJ
    J Parenter Drug Assoc; 1980; 34(3):167-74. PubMed ID: 6901772
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations to pharmacists for solving problems with large-volume parenterals-1979. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):663-7. PubMed ID: 7386474
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of particulate matter in large volume parenterals.
    Krueger EO
    Bull Parenter Drug Assoc; 1972; 26(2):96-100. PubMed ID: 5012209
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaches to reducing subvisible particle counts in lyophilized parenteral formulations.
    Gupta PK; Porembski E; Williams NA
    J Pharm Sci Technol; 1994; 48(1):30-7. PubMed ID: 8004415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hygienic standard of parenteral solutions.
    Winding O
    Ugeskr Laeger; 1977 Dec; 139(49):2940-4. PubMed ID: 595183
    [No Abstract]   [Full Text] [Related]  

  • 8. Theoretical aspects of particulate matter monitoring by microscopic and instrumental methods.
    Schroeder HG; Deluca PP
    J Parenter Drug Assoc; 1980; 34(3):183-91. PubMed ID: 6901774
    [No Abstract]   [Full Text] [Related]  

  • 9. Particulate matter in parenteral products: a review.
    Borchert SJ; Abe A; Aldrich DS; Fox LE; Freeman JE; White RD
    J Parenter Sci Technol; 1986; 40(5):212-41. PubMed ID: 3540253
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of two methods for obtaining size distribution characteristics of particulate matter in large-volume parenterals.
    Blanchard J; Schwartz JA; Byrne DM; Marx DB
    J Pharm Sci; 1978 Mar; 67(3):340-4. PubMed ID: 641718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for the labeling of large volume parenterals. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1978 Jan; 35(1):49-51. PubMed ID: 623118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New cleanliness assessement for particulate matters in large-volume parenteral injection].
    Tsuji S; Isaka H
    Yakugaku Zasshi; 1987 Mar; 107(3):238-44. PubMed ID: 3598875
    [No Abstract]   [Full Text] [Related]  

  • 14. Overview of the International Conference on Particle Detection, Metrology, and Control.
    Knapp JZ; Barber TA
    J Parenter Sci Technol; 1990; 44(5):257-63. PubMed ID: 1979082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical feasibility of sub-visible particle analysis in parenterals with reduced volume light obscuration methods.
    Hawe A; Schaubhut F; Geidobler R; Wiggenhorn M; Friess W; Rast M; de Muynck C; Winter G
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1084-7. PubMed ID: 23454051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particulate contamination of parenterals.
    Dando W
    Anesth Prog; 1979; 26(5):127-8. PubMed ID: 298460
    [No Abstract]   [Full Text] [Related]  

  • 17. Standards for particulate matter in all parenteral drug products.
    Jeffrey LP; Pinkus TF
    Am J Hosp Pharm; 1976 Sep; 33(9):879-80. PubMed ID: 984053
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of three optical systems to obtain a microscopic profile of asbestos and other nonopaque particulate matter larger than 5 mum in parenteral drugs.
    Auerbach L
    J Assoc Off Anal Chem; 1977 Mar; 60(2):289-96. PubMed ID: 320173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silting index determination--an alternative to particle counting for the control of particulate contamination in infusion fluids.
    Ernerot L
    Acta Pharm Suec; 1974 Feb; 11(1):15-24. PubMed ID: 4816412
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality control guidelines for single unit packaging of parenterals in the hospital pharmacy.
    Patel JA; Curtis EG; Phillips GL
    Am J Hosp Pharm; 1972 Nov; 29(11):947-51. PubMed ID: 4655003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.